Dr. Clint Cary - Retroperitoneal Lymph Node Diessection (RPLND)
Dr. Clint Cary, Retroperitoneal Lymph Node Dissection (RPLND)
Welcome to Episode 10 of It Takes Balls!
In this episode of It Takes Balls, Dr. Clint Cary of Indiana University Health, talks about retroperitoneal lymph node dissection (RPLND) and its role in treating testicular cancer.
Dr. Cary explains the complexity of RPLND, a procedure to remove lymph nodes near major blood vessels in the abdomen, often performed when testicular cancer spreads. He emphasizes the importance of undergoing this rare and intricate surgery at high-volume centers, as experience significantly impacts outcomes.
The conversation also addresses key patient questions, including:
Surgery vs. Chemotherapy: Indiana University often opts for surgery to avoid the long-term side effects of chemotherapy, such as secondary cancers and cardiovascular risks.
Open vs. Robotic RPLND: While robotic surgery is gaining interest, Dr. Cary highlights its risks and notes that open surgery remains the standard of care.
Nerve-Sparing Techniques: Dr. Cary explains how preserving nerves during surgery can maintain ejaculation function, though post-chemotherapy scarring can complicate this.
Diet and Recovery: Post-surgery dietary guidelines vary, but Indiana’s low complication rates allow for a more balanced approach, avoiding overly strict restrictions.
Dr. Cary also touches on new biomarkers, such as microRNA, that could one day predict the need for surgery, potentially sparing patients from invasive procedures. He encourages patients to seek care at experienced centers and to advocate for broader awareness of surgical options.
